|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Review of Library Collection Development Policies: Academic, Public, and Special Libraries 显示文摘 | Ganson J | 2006 | Reference & User Services Quarterly2006，，45： | 1 |
| 2 | Pharmacolinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout显示文摘 | Sundy JS Ganson N J Kelly S J | 2007 | Arthr Rheum2007，56，： | 1 |
| 3 | Control of hyperuri- cemia in subjects with refractory gout, and induction of anti- body against poly(ethylene glycol)(PEG), in a phase I trial of subcutaneous PEGylated urate oxidase显示文摘 | Ganson N J Kelly S J Scarlett E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
| 4 | Pharmacokinetics and phar- macodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout 显示文摘 | Sundy JS Ganson N J Kelly S J | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 5 | Control of hyperuricemia in subjects with refractory gout,and induction of antibody against poly(ethylene glycol)(PEG),in a phase I trial of subcutaneous PEGylated urate oxidase显示文摘 | Ganson N J Kelly S J Scarlett E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
| 6 | Control of hyperuricemia in subjects with refractory gout,and induction of antibody against poly (ethylene glycol) (PEG) , in a phase I trial of subcutaneous PEGylated urate oxidase显示文摘 | Ganson NJ Kelly S J Scarlett E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
| 7 | Pharmacokinetics andpharmacodynamics of intravenous PEGylated recombinantmammalian urate oxidase in patients with refractory gout 显示文摘 | Sundy J S Ganson N J Kelly S J | 2007 | Arthritis Rheum2007，56，6： | 1 |
| 8 | Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly ( ethylene glycol ) ( PEG ), in a phase I trial of subcutaneous pegylated urate oxidase 显示文摘 | GANSON N J KELLY S J SCARLETF E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
| 9 | Pharmacokinetics and pharmacodynamics of intravenous pegylated recombinant mammalian urate oxidase in patients with refractory gout 显示文摘 | SUNDY J S GANSON N J KELLY S J | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 10 | Control of hyper- uricemia in subjects with refractory gout, and induction of antibody against poly (ethylene glycol) (PEG) , in a phase I trial of subcutaneous PEGylated urate oxidase显示文摘 | Ganson NJ Kelly S J Scarlett E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
| 11 | Air/surface exchange of mercury vapor over forests-the need for a reassessment of continental biogenic emissions显示文摘 | LINDBERG S E GANSON P J MEYERS T P | 1998 | Atmos Environ1998，32，5： | 1 |
| 12 | Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate xidase in patients with refractory gout 显示文摘 | Sundy JS Ganson N J Kelly S J | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 13 | Control of hyperuricemia in subjects with refractory, gout, and induction of antibody against poly (ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylatcd urate oxidase 显示文摘 | Ganson N J Kelly S J Scarlett E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
| 14 | Pharmacokinetics and pharmacodynamics of intravenous pegylated recombinant mammalian urale oxidase in patients wifll refraclorv gout 显示文摘 | Sundy JS Ganson N J Kelly SJ | 2007 | Arlhritis Rheum2007，56，3： | 1 |
| 15 | Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly (ethylene glycol) (PEG) , in a phase I trial of subcutaneous PEGylated urate oxidase显示文摘 | Ganson N J Kelly SJ Scarlett E | 2006 | Arthritis Research & Therapy2006，8，1： | 1 |
| 16 | Pharmacokinetics and phar- macodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout 显示文摘 | Sundy JS Ganson N J Kelly SJ | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 17 | Control of hyperttrieemia in subjects with refractory gout, and induction of antibody against poly (ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase显示文摘 | Ganson N J Kelly g J Scarlett E | 2006 | Arthritis Res Ther2006，8，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员